A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

Starting soon · Phase 1

Conditions studied: Benign Prostatic Hyperplasia

In brief

This study compares and evaluates the bioequivalence of AD-116A and AD-1161 in healthy adult male volunteers under fed conditions.

Key facts

Study ID

NCT07722871

Run by

Addpharma Inc.

People needed

44

Starts

2026-07-01

Expected to finish

2026-10-01

Last updated by the study team

2026-07-27

Who can join

Age: 19 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Body weight equal to or greater than 50 kg and body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
• Age equal to or greater than 19 years in healthy adult male volunteers at the time of screening visit

You may not qualify if…

• Participation in another clinical study with an investigational drug within 6 months prior to the scheduled first administration
• Other exclusions applied

Where it is running

• H PLUS YANGJI HOSPITAL, Seoul — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.